Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Pharmacokinetic, Pharmacodynamic, Safety and Efficacy Study of Three Anti-CD20 Monoclonal Antibodies in Patients With Moderate to Severe Rheumatoid Arthritis

NCT02296775 is registered in ClinicalTrials.gov with Dr. Reddy's Laboratories Limited as lead sponsor.

NCT NCT02296775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02296775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Pharmacokinetic, Pharmacodynamic, Safety and Efficacy Study of Three Anti-CD20 Monoclonal Antibodies in Patients With Moderate to Severe Rheumatoid Arthritis
Lead sponsor
Dr. Reddy's Laboratories Limited
Phase
Phase 1/2
Overall status
Completed
Start date
November 30, 2014
Completion date
October 5, 2017
Enrollment
276 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis